ResMed Inc (BSP:R1MD34)
R$ 368.7 0.14 (0.04%) Market Cap: 216.49 Bil Enterprise Value: 218.91 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 87/100

Resmed Inc at Bank of America Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 04:35PM GMT
Release Date Price: R$391.16
Lyanne Harrison
BofA Securities, Research Division - VP

Hello all, and welcome. My name is Lyanne Harrison, and I'm Bank of America's health care analyst here in Australia. Today, we are fortunate to have with us Rob Douglas, Chief Operating Officer of ResMed; and David Pendarvis, Chief Administrative Officer. Hi, Rob. Hi, Dave. Thank you for taking the time to speak with us.

Robert A. Douglas
ResMed Inc. - President & COO

Hi, Lyanne, thanks for that.

David B. Pendarvis
ResMed Inc. - Chief Administrative Officer, Global General Counsel & Corporate Secretary

It's good to be here.

Robert A. Douglas
ResMed Inc. - President & COO

Yes. Lyanne...

Lyanne Harrison
BofA Securities, Research Division - VP

I wanted to tell you -- sorry, can you hear me?

Robert A. Douglas;Lyanne Harrison
ResMed Inc. - President & COO;

Yes, you go, Lyanne.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot